NGR-hTNF and doxorubicin in relapsed small-cell lung cancer (SCLC)

被引：0
|
作者：
Cavina, Raffaele
Gregorc, Vanesa
Novello, Silvia
Grossi, Francesco
Santoro, Armando
Vigano, Maria Grazia
Levra, Matteo G.
Lambiase, Antonio
Bordignon, Claudio
机构：
[1] Humanitas Canc Ctr, Rozzano, Italy
[2] Ist Sci San Raffaele, Dept Oncol, Milan, Italy
[3] Univ Turin, Thorac Oncol Unit, AUO San Luigi, Orbassano, Italy
[4] Natl Canc Res Ctr, Lung Canc Unit, Genoa, Italy
[5] Humanitas Canc Ctr, Dept Oncol, Rozzano, Italy
[6] MolMed, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7085
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Treatment options for relapsed small-cell lung cancer
    Azim, Hatem A., Jr.
    Ganti, Apar Kishor
    ANTI-CANCER DRUGS, 2007, 18 (03) : 255 - 261
  • [32] Amrubicin hydrochloride for relapsed small-cell lung cancer
    Byron, Elizabeth
    Chiappori, Alberto
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (12): : 1041 - 1047
  • [33] SINGLE-DOSE ETOPOSIDE IN COMBINATION WITH VINCRISTINE AND DOXORUBICIN IN THE TREATMENT OF SMALL-CELL LUNG-CANCER (SCLC)
    TIMOTHY, AR
    CALMAN, FMB
    BATEMAN, NT
    FAREBROTHER, M
    SLEVIN, ML
    BELLAMY, D
    RUBENS, RD
    COSTELLO, J
    SEMINARS IN ONCOLOGY, 1985, 12 (01) : 45 - 47
  • [34] A 2022 Update on Extensive Stage Small-Cell Lung Cancer (SCLC)
    Oronsky, Bryan
    Abrouk, Nacer
    Caroen, Scott
    Lybeck, Michelle
    Guo, Xiaoning
    Wang, Xiaohui
    Yu, Zhongwen
    Reid, Tony
    JOURNAL OF CANCER, 2022, 13 (09): : 2945 - 2953
  • [35] Second-line chemotherapy for small-Cell Lung Cancer (SCLC)
    Kim, Young Hak
    Mishima, Michiaki
    CANCER TREATMENT REVIEWS, 2011, 37 (02) : 143 - 150
  • [36] RANDOMIZED PHASE II TRIAL OF NGR-HTNF AND CHEMOTHERAPY IN CHEMO-NAIVE PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC): PRELIMINARY RESULTS.
    Gregorc, Vanesa
    Zilembo, N.
    Grossi, Francesco
    Rossoni, Gilda
    Pietrantonio, Filippo
    Rijavec, Erika
    Bulotta, Alessandra
    Vitali, Milena
    Barletta, Giulia
    Bergamaschi, Luca
    Platania, Marco
    Lambiase, Antonio
    Bordignon, Claudio
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S661 - S662
  • [37] Two doses of NGR-hTNF (N) given alone or in combination with doxorubicin (D) in soft tissue sarcomas (STS)
    Ferrari, Stefano
    Casali, Paolo Giovanni
    Blay, Jean-Yves
    Tonini, Giuseppe
    Le Cesne, Axel
    Ali, Nasim
    Perfetti, Vittorio
    Palmerini, Emanuela
    Palassini, Elena
    Ray-Coquard, Isabelle
    Vincenzi, Bruno
    Domont, Julien
    Marchesi, Emanuela
    Marrari, Andrea
    Cassier, Philippe Alexandre
    Silletta, Marianna
    Stacchiotti, Silvia
    Lambiase, Antonio
    Bordignon, Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer
    Farago, Anna F.
    Yeap, Beow Y.
    Stanzione, Marcello
    Hung, Yin P.
    Heist, Rebecca S.
    Marcoux, J. Paul
    Zhong, Jun
    Rangachari, Deepa
    Barbie, David A.
    Phat, Sarah
    Myers, David T.
    Morris, Robert
    Kem, Marina
    Dubash, Taronish D.
    Kennedy, Elizabeth A.
    Digumarthy, Subba R.
    Sequist, Lecia V.
    Hata, Aaron N.
    Maheswaran, Shyamala
    Haber, Daniel A.
    Lawrence, Michael S.
    Shaw, Alice T.
    Mino-Kenudson, Mari
    Dyson, Nicholas J.
    Drapkin, Benjamin J.
    CANCER DISCOVERY, 2019, 9 (10) : 1372 - 1387
  • [39] SALVAGE NOGITECAN CHEMOTHERAPY FOR RELAPSED SMALL-CELL LUNG CANCER
    Hiyoshi, Y.
    Fukui, T.
    Nagashima, Y.
    Takakura, A.
    Katono, K.
    Yokoba, M.
    Sasaki, J.
    Masuda, N.
    ANNALS OF ONCOLOGY, 2013, 24 : 79 - 79
  • [40] LURBINECTEDIN IS SAFE AND ACTIVE IN RELAPSED SMALL-CELL LUNG CANCER
    不详
    CANCER DISCOVERY, 2020, 10 (06) : 757 - 757
12345